European countries can continue to use the Johnson and Johnson COVID-19 vaccine. E.U. regulators say there are possible links to rare blood clot incidents, but said the benefits of the vaccine outweigh the risks.
The European Medicines Agency said a warning about using the vaccine with low blood platelets should be added. The agency said it researched all the cases of blood clotting, including one fatal case. More than seven-million Americans received the vaccine before it was paused here in the United States. There were eight reports of clotting, with six being series and of those, one death. Each EU member will have to decide if they will use the Johnson and Johnson vaccine.
Read the full article here.
SOURCE: BBC News